1,322 reports of this reaction
4.1% of all MECLIZINE HCL 12.5MG reports
#1 most reported adverse reaction
DIZZINESS is the #1 most commonly reported adverse reaction for MECLIZINE HCL 12.5MG, manufactured by Advanced Rx LLC. There are 1,322 FDA adverse event reports linking MECLIZINE HCL 12.5MG to DIZZINESS. This represents approximately 4.1% of all 32,433 adverse event reports for this drug.
Patients taking MECLIZINE HCL 12.5MG who experience dizziness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIZZINESS is moderately reported among MECLIZINE HCL 12.5MG users, representing a notable but not dominant share of adverse events.
In addition to dizziness, the following adverse reactions have been reported for MECLIZINE HCL 12.5MG:
The following drugs have also been linked to dizziness in FDA adverse event reports:
DIZZINESS has been reported as an adverse event in 1,322 FDA reports for MECLIZINE HCL 12.5MG. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIZZINESS accounts for approximately 4.1% of all adverse event reports for MECLIZINE HCL 12.5MG, making it one of the most commonly reported side effect.
If you experience dizziness while taking MECLIZINE HCL 12.5MG, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.